According to Janux Therapeutics's latest financial reports the company has a price-to-book ratio of 9.40.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.44 | -15.91% |
2022-12-31 | 1.71 | -23.67% |
2021-12-31 | 2.24 | |
2020-12-31 | N/A |